Advanced Biomed Inc
ADVB
3 hedge funds and large institutions have $13.2K invested in Advanced Biomed Inc in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0.05% less ownership
Funds ownership: 0.06% → 0.01% (-0.05%)
40% less funds holding
Funds holding: 5 → 3 (-2)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
89% less capital invested
Capital invested by funds: $116K → $13.2K (-$103K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$401 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$62.5K |
| 2 |
HF
HRT Financial
New York
|
-$15K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$10.4K |
| 4 |
VF
Virtu Financial
New York
|
-$8.14K |
ADVB Hedge Fund Activity: Q4 2025 in Review
3 of the 8,229 institutional investors tracked by Wall St. Rank reported a position in Advanced Biomed Inc (ADVB) for Q4 2025, worth a combined $13.2K — down 89% from $116K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ADVB and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $401. The largest seller was Citadel Advisors, exiting entirely with an estimated $62.5K sold.
- 3 institutional investors held Advanced Biomed Inc (ADVB) as of Q4 2025, down from 5 in Q3 2025.
- Funds reported $13.2K of Advanced Biomed Inc stock for Q4 2025, down 89% quarter-over-quarter.
- 0 funds opened new Advanced Biomed Inc positions in Q4 2025 and 2 closed out, a net change of -2 holders.
- The largest Advanced Biomed Inc buyer in Q4 2025 was UBS Group, an estimated $401 added.
- The largest Advanced Biomed Inc seller in Q4 2025 was Citadel Advisors, an estimated $62.5K sold.
Based on aggregated 13F filings for Q4 2025.